Massimo D'amore
Bari, 70124, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
Journal: International immunology
Published: November 10, 2014
ADAM17 at the interface between inflammation and autoimmunity.
Journal: Immunology letters
Published: June 06, 2014
Neovascularization is prominent in the chronic inflammatory lesions of Sjögren's syndrome.
Journal: International journal of experimental pathology
Published: April 29, 2014
Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren syndrome.
Journal: Immunology
Published: January 15, 2014
The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sjögren's syndrome.
Journal: Clinical and experimental medicine
Published: January 14, 2014
Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren's syndrome.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: November 05, 2013
Paget's disease of bone: new therapeutic strategies
Journal: Recenti progressi in medicina
Published: April 04, 2013
GRO-α/CXCR2 system and ADAM17 correlated expression in Sjögren's syndrome.
Journal: Inflammation
Published: February 08, 2013
Salivary gland expression level of IκBα regulatory protein in Sjögren's syndrome.
Journal: Journal of molecular histology
Published: December 04, 2012
A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome: regulatory effects of pro-inflammatory cytokines.
Journal: Histochemistry and cell biology
Published: September 18, 2012
Emerging avenues linking inflammation, angiogenesis and Sjögren's syndrome.
Journal: Cytokine
Published: July 20, 2012
Last Updated: 09/26/2026